Albemarle (ALB) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Albemarle reported miserable Q2 earnings on Wednesday, losing nearly $2 per share. Wall Street was quick to cut price targets, but most analysts still think Albemarle stock is a long-term buy.
Albemarle Corporation (NYSE:ALB ) Q2 2024 Earnings Conference Call August 1, 2024 8:00 AM ET Company Participants Meredith Bandy - VP, IR and Sustainability Jerry Kent Masters, Jr. - Chairman, President, and CEO Neal R. Sheorey - EVP and CFO Netha N.
While Albemarle (ALB) benefits from higher volumes, lower lithium market pricing weighed on its results in the second quarter.
Although the revenue and EPS for Albemarle (ALB) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Albemarle (ALB) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $7.33 per share a year ago.
Albemarle , the world's largest lithium producer, said on Wednesday it would slash costs for the second time this year and that everything but its dividend could be on the chopping block.
As the world accelerates its transition towards renewable energy, battery stocks remain at the forefront of this global shift. Heading into the summer of 2024, the demand for high-performance, sustainable battery solutions is more critical than ever.
The mining sector is one of the most dynamic yet controversial industries to be investing in. When we talk about mining stocks, there are a plethora of different commodities to explore.
Investors need to pay close attention to Albemarle (ALB) stock based on the movements in the options market lately.
Evaluate the expected performance of Albemarle (ALB) for the quarter ended June 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Albemarle (ALB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.